Literature DB >> 6142647

Adrenergic mechanisms in the control of plasma lipids in man.

J L Day, J Metcalfe, N Simpson, L Lowenthal.   

Abstract

The effects on plasma lipids of beta-blocking antihypertensive agents with differing degrees of selectivity and intrinsic sympathomimetic activity were studied. The interrelationship between changes in lipid factors, lipoprotein lipase function, the degree of response, and pretreatment characteristics were examined. Beta-adrenergic blockade increased plasma triglycerides but decreased high-density lipoprotein cholesterol. Cardioselective drugs (atenolol and metoprolol) had less effect on triglyceride and very low-density lipoprotein cholesterol than the nonselective beta blockers (propranolol and oxprenolol). Inhibition of lipoprotein lipase was suggested by a reduction of the fractional removal rate of triglyceride in conjunction with increased total and very low-density lipoprotein cholesterol levels and reduced high-density lipoprotein cholesterol. Consistent decreases in free fatty acids lend argument against elevated triglyceride synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142647     DOI: 10.1016/0002-9343(84)90963-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.

Authors:  Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-04-04       Impact factor: 1.880

2.  Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.

Authors:  A Steinmetz; A Kirklies; G Schlosser; W Cassel; J H Peter; K Ehlenz; J R Schäfer; P V Wichert; H Kaffarnik
Journal:  Clin Investig       Date:  1993-02

Review 3.  Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.

Authors:  G L Plosker; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

4.  Withdrawal of chronic beta-adrenoceptorblockade: effects on haemodynamics, blood lipids and haemostatic variables.

Authors:  P Smith; I Seljeflot; T Opstad
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Epidemiology of cardiovascular disease risk factors in Catalonia (Spain).

Authors:  P Plans; H Pardell; L Salleras
Journal:  Eur J Epidemiol       Date:  1993-07       Impact factor: 8.082

6.  Oslo Hypertension Study.

Authors:  P Leren; A Helgeland
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.